Pharmaceutical Biotechnology explores the development of protein-based therapeutic substances.
• Provides a working knowledge of the preparation, stability, and formulation of protein and peptide drugs
• Examines the successful evolution of humanized monoclonal antibodies (MAbs) to treat rheumatoid arthritis and other diseases
• Considers the currently disappointing results of genetic engineering and genomics that have isolated disease-responsible genes without significant clinical effect to date
• Looks at the market and scientific reasons behind the failure of many biotechnology products to live up to their hype
• Discusses regulatory and compendial issues and concludes with a look at future challenges facing biotechnology